Anti-Cathepsin S Rabbit Polyclonal Antibody
- Host
- Rabbit, Polyclonal
- Reactivity
- Validated- Human Potential-Mouse, Rat, Pan, Dog
- UniProt
- P25774
- Size
- 100ug
- Cat. #
- RP2CathepsinS
In stock
- SKU
- RP-CathepsinS
Target Overview
Cathepsin S (CTSS, EC 3.4.22.27, UniProt P25774) is a lysosomal cysteine protease of 331 amino acids that plays a critical role in MHC class II-mediated antigen presentation. As a thiol protease with substrate specificity partially overlapping that of cathepsin L, cathepsin S is the principal enzyme responsible for cleaving the invariant chain (Ii) from MHC class II molecules in antigen-presenting cells, a requisite step for peptide loading and immune surveillance. Beyond its canonical immunological function, cathepsin S has been implicated in extracellular matrix remodeling, pruritus through cleavage and activation of the sensory receptor MRGPRX1, and diverse pathological processes including chronic kidney disease, leukemia progression, and tissue remodeling in chronic rhinosinusitis. The enzyme is synthesized as a proenzyme requiring proteolytic maturation within the acidic lysosomal compartment, where it remains catalytically active even at neutral pH, distinguishing it from many related cathepsins.
Background
Cathepsin S occupies a unique niche among lysosomal cysteine proteases due to its restricted expression pattern—primarily in antigen-presenting cells such as dendritic cells, macrophages, and B lymphocytes—and its unusual pH stability. While most cathepsins are rapidly inactivated at neutral pH, cathepsin S retains activity across a broad pH range, enabling it to function in both endosomal compartments and, under pathological conditions, in the extracellular space. This property underlies its involvement in basement membrane degradation, elastin cleavage, and tissue remodeling events that extend well beyond antigen processing. Recent work has demonstrated that cathepsin S deficiency mitigates chronic stress-related renal remodeling and dysfunction in a 5/6 nephrectomy mouse model, implicating the protease in fibrotic pathways (Wang et al., 2026, PMID 42247209). Separately, growth differentiation factor-11 was shown to inhibit acute myeloid leukemia progression by suppressing cathepsin S activity, pointing to a regulatory axis in hematologic malignancy.
In inflammatory airway disease, cathepsin S has emerged as a biomarker for tissue remodeling in chronic rhinosinusitis with nasal polyps, where multi-omics analyses position CTSS as a hub gene linking immune infiltration and extracellular matrix turnover. The enzyme's capacity to process and activate G protein-coupled receptors also extends its influence into sensory neurobiology, where cathepsin S-mediated cleavage of MRGPRX1 elicits itch responses. Collectively, these findings underscore cathepsin S as a multifunctional protease with relevance to immunology, fibrosis, oncology, and neuroinflammation, making it a recurrent target in translational research across multiple disease contexts.
References
- Wang H et al (2026) Cathepsin S Deficiency Prevents Chronic Stress-Related Renal Remodeling and Dysfunction in a Mouse 5/6 Nephrectomy Injury Model. FASEB J. PubMed · 10.1096/fj.202601039R
- Luo J et al (2026) Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S. Anticancer Drugs. PubMed · 10.1097/CAD.0000000000001832
- Li C et al (2026) CTSS as a novel biomarker for tissue remodeling in CRSwNP: insights from multi-omics research. Rhinology. PubMed · 10.4193/Rhin25.504
- Mao Z et al (2026) Elucidating the pathogenic mechanism underlying plasticizer-induced chronic kidney disease via integrated network toxicology and machine learning. Ecotoxicol Environ Saf. PubMed · 10.1016/j.ecoenv.2026.120309
- Kolmos M et al (2026) Biomarkers of plasticity and recovery after stroke: Insights from the PRACTISE trial. Clin Neurol Neurosurg. PubMed · 10.1016/j.clineuro.2026.109492
Additional Specifications
| Gene Symbol | CTSS |
|---|---|
| UniProt ID | P25774 |
| Host Species | Rabbit |
| Species Reactivity | Validated- Human Potential-Mouse, Rat, Pan, Dog |
| Pack Size | 100ug |
| Immunogen (Propeptide domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 17-114. |
| Immunogen (Catalytic domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 115-331. |
| Alternate Names | CTSS, EC 3.4.22.27, Cathepsin S |
Frequently Asked Questions
What molecular weight should I expect for Cathepsin S on a Western blot?
Cathepsin S migrates as multiple bands reflecting its proteolytic maturation. The full-length zymogen (procathepsin S) runs at approximately 37-38 kDa. Following N-terminal propeptide cleavage in the lysosome, the mature active form appears at 24-28 kDa, which is the predominant species in most lysates from antigen-presenting cells. You may observe both forms depending on cell type and activation state. Glycosylation can add 2-3 kDa heterogeneity. Reducing conditions are standard; cathepsin S is a monomeric enzyme and does not require non-reducing gels for detection.
What dilution should I start with for Western blot and IHC with this cathepsin S antibody?
For Western blot, begin at 1:1000 dilution in 5% non-fat milk or BSA in TBST, which is our validated starting point for most human lysates. For IHC on formalin-fixed paraffin-embedded tissue, a range of 1:100 to 1:500 typically works after antigen retrieval in citrate buffer, pH 6.0. Expression varies considerably by cell type—cathepsin S is abundant in professional antigen-presenting cells such as dendritic cells, macrophages, and B cells, but low in most epithelial tissues. Titre the antibody against your specific sample type and fixation protocol to optimize signal-to-noise.
Is this antibody specific for cathepsin S or does it cross-react with other cathepsins?
This polyclonal was raised against a cathepsin S-specific immunogen and shows no detectable cross-reactivity with cathepsin L, K, or B in our validation panel, despite partial sequence homology among cysteine cathepsins. However, as with any polyclonal reagent, we recommend including a cathepsin S knockout lysate or siRNA knockdown control in your first experiment to confirm specificity in your biological system. Cathepsin S shares approximately 60% identity with cathepsin L in the catalytic domain, so orthogonal validation is good practice when interpreting expression patterns or colocalization studies.
Will this cathepsin S antibody work in mouse and rat samples?
Cross-reactivity with mouse and rat cathepsin S is predicted based on epitope homology but not yet validated in-house. Human and mouse cathepsin S share approximately 86% amino acid identity, and human-rat homology is similar. Several customers have reported successful detection in murine macrophage and dendritic cell lysates at 1:500 to 1:1000 dilution, but we advise running a positive control—such as LPS-stimulated bone marrow-derived dendritic cells—alongside your samples during optimization. If working exclusively with rodent models, request lot-specific data or plan a pilot Western to confirm signal before committing to large-scale experiments.
What sample preparation is recommended for detecting cathepsin S in cell lysates?
Use standard RIPA or NP-40 lysis buffer supplemented with protease inhibitor cocktail to preserve cathepsin S integrity. Because cathepsin S is a lysosomal protease, avoid freeze-thaw cycles that can cause lysosomal rupture and autocatalytic degradation. Process lysates on ice and snap-freeze aliquots in liquid nitrogen if long-term storage is required. For subcellular fractionation studies, be aware that cathepsin S is secreted by some immune cells and traffics through the endosomal-lysosomal pathway. Expected expression is highest in monocyte-derived cells, splenic macrophages, and microglia; low or absent in fibroblasts and most non-immune cell lines.
Can I use this antibody to detect extracellular or secreted cathepsin S?
Yes, but with caveats. While cathepsin S is primarily lysosomal, it is secreted by activated macrophages, dendritic cells, and some tumor cells, particularly under inflammatory conditions or in the tumor microenvironment. If detecting secreted cathepsin S in conditioned media or serum by Western blot, concentrate samples by TCA precipitation or ultrafiltration; secreted levels are typically 10- to 50-fold lower than intracellular. For ELISA-based quantification of soluble cathepsin S, a matched-pair sandwich immunoassay is more sensitive. This polyclonal will recognize both pro- and mature forms in extracellular compartments.
What positive and negative controls should I include when using this cathepsin S antibody?
Positive controls with robust cathepsin S expression include THP-1 cells differentiated with PMA, human peripheral blood monocyte-derived dendritic cells, or Raji B-cell lysates. Murine RAW 264.7 macrophages are a reasonable rodent positive control if cross-reactivity is confirmed. For negative controls, HEK293T or NIH-3T3 fibroblasts express negligible cathepsin S. The most rigorous specificity control is a lysate from cathepsin S-knockout cells or siRNA-treated samples run in parallel. Given cathepsin S upregulation in inflammation, consider stimulating cells with IFN-gamma or LPS to amplify signal during optimization.
How should I store this cathepsin S antibody and what is the shelf life?
Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase background. The antibody is supplied in PBS with glycerol and 0.02% sodium azide as preservative. Under these conditions, stability is typically greater than 12 months from date of receipt. For long-term storage beyond one year, keep at -80°C. Once thawed, an aliquot can be held at 4°C for up to one month if 0.02% azide is present. Do not store diluted antibody in working solutions for more than one week; prepare fresh dilutions for best results.
Western blot validation for RP-CathepsinS — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.
Custom validation studies available on request — contact us.
Also known as:
- CTSS
- EC 3.4.22.27
- Cathepsin S